Human Platelet Lysate, Fibrinogen-Depleted, Xeno-Free

Growth factor-rich supplement for the expansion of cells in vitro

产品优势

未找到
Start experiments confidently with a reliable supply of ethically sourced, xeno-free, fibrinogen-depleted, human platelet lysate (hPL) for the expansion of cells in vitro. We help you get the blood-derived products you need with personalized service and flexible delivery times.

An alternative to fetal bovine serum (FBS), this growth factor-rich cell culture supplement was derived from healthy donor human platelets, and multiple donor units were pooled during manufacturing to minimize lot-to-lot variability. Heparin was not added during the manufacturing process and is not required for use of this product.

Human platelet lysate is sourced from US FDA-registered, AABB-certified blood banks in the United States. Units must have been acceptable for allogeneic transfusion prior to expiration.

Consent is obtained from volunteers participating in a donor collection program that is reviewed and/or approved by either an Institutional Review Board (IRB), the Food and Drug Administration (FDA), U.S. Department of Health and Human Services and/or an equivalent regulatory authority.

Certain products are only available in select territories. Please contact your local sales representative or Product & Scientific Support at techsupport@stemcell.com for further information. Browse our Frequently Asked Questions (FAQs) on Primary Cells.

Data Figures

Properties of Human Platelet Lysate Cell Culture Supplements for Ex Vivo Cell Expansion

Figure 1. Properties of Human Platelet Lysate Cell Culture Supplements for Ex Vivo Cell Expansion

The human platelet lysate (hPL) product recommended for the expansion of cells ex vivo varies depending on the starting cell type, intended application, and experimental compliance required. (1) Fibrinogen has not been depleted, therefore addition of an anticoagulant (e.g. Heparin Solution; Catalog #07980) is required to inhibit coagulation. (2) Fibrinogen has been depleted during manufacturing. Pharmaceutical-grade heparin derived from porcine intestine is used in the manufacturing process and the concentration of heparin in final product is ≤ 2 IU/mL. (3) Fibrinogen has been depleted during manufacturing; heparin is not added during the manufacturing process and addition of anticoagulants is not required for use of this product.

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
200-0360, 200-0361, 200-0362
Lot #
All
Language
English
Document Type
Safety Data Sheet
Catalog #
200-0360, 200-0361, 200-0362
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. FOR ADDITIONAL INFORMATION ON QUALITY AT STEMCELL, REFER TO WWW.STEMCELL.COM/COMPLIANCE.
版权 © 2025 STEMCELL Technologies 技术有限公司。保留所有权利。